openPR Logo
Press release

Clinical Radiation Oncology Training at Mannheim Medical Centre, Germany

06-20-2011 09:15 AM CET | Health & Medicine

Press release from: Dharamshila Hospital and Research Centre

Cancer Hospital India

Cancer Hospital India

New Delhi, June 17, 2011 : Dharamshila Hospital And Research Centre has recently acquired a new Elekta Synergy Linear Accelerator capable of IMRT, IGRT, SRS, SRT and SBRT. The clinical and technical application training of this machine is usually scheduled at a teaching Hospital in Germany. Dr. Hari Mohan, Consultant – Radiation Oncology, Dharamshila Hospital visited Mannheim Medical Centre, Germany for clinical training on Elekta Synergy.

Mannheim Medical Centre, Germany is affiliated to University of Heidelberg, Germany, the oldest university of Germany. The department of Radiation Oncology at this hospital is equipped with CT simulator, 3 Linear Accelerators, intraoperative Brachytherapy for breast, head and neck and pelvic tumors and interstitial Brachytherapy with iodine seeds for prostate cancer.

He has received a first hand experience of treatment planning with VMAT on Monaco planning system. It was enlightening to know the protocols and planning methodology being used at this centre. All the patients undergo CT simulation as a routine and are planned for radiotherapy with utmost care and compassion. Respiratory gating is used for tumors of lung, breast and chest wall.

The treatment is planned with Oncentra Masterplan, for 3D-conformal radiotherapy and with 5 different inverse treatment planning systems (Corvus, Oncentra Masterplan and preciseplan exclusively for static IMRT, Ergo+++ for VMAT treatments and Monaco for both static and VMAT treatments).

He saw IGRT being performed with stereotactic ultrasound and with X-ray volume imaging (Cone Beam CT, Elekta XVI on Elekta synergy).

Treatments were recorded with the MOSAIQ Electronic Medical Record (EMR) of the patient. MOSAIQ oncology PACS archives all critical data.
IMRT was used for the treatment of almost all patients of Head and neck, prostate and stomach. Tumor relapses near the spine were also treated with IMRT. IGRT protocols are strictly followed for all IMRT patients.

He got experience in Extracranial frameless SRT with image guidance (IGRT). In addition, LDR brachytherapy for prostate cancer is also available.

The department actively collaborates with other departments within the framework of Comprehensive Cancer Centre. This was very similar to the tumor board meeting which we routinely conduct at our hospital wherein every new cancer patient’s management plan collaboratively is arrived at after a joint meeting with Radiation, Medical and surgical oncologists together with oncopathologist and imaging oncology experts.

We at Dharamshila Hospital, have the same setup for Radiotherapy treatment and planning. In addition, we also have Nucletron HDR Brachytherapy facilities which are not there at Mannheim Medical Centre. It is indeed a pleasure to realize that we have the same world class technology which is available at most of the top institutes all over the world. We have been treating our patients with IMRT for the last 6 years and IGRT with VMAT is also now fully functional. That brings us at par with some of the best Radiotherapy departments across the globe. And we sincerely hope that the treatment outcome of our cancer patients will now also be at par with the best internationally accepted standards.

A group of concerned relatives and friends of cancer patients felt the need to provide complete cancer treatment under one roof. They felt it was their Dharma (duty) to provide to cancer patients what was not available to their near and dear ones when they suffered with cancer.

Dharamshila Hospital and Research Centre
Dharamshila Marg, Vasundhara Enclave
Delhi - 110096, INDIA
Website -

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Radiation Oncology Training at Mannheim Medical Centre, Germany here

News-ID: 179890 • Views: 2285

More Releases from Dharamshila Hospital and Research Centre

Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
A 25 year old IT professional was struck with Hodgkin ’s disease which is one of the most curable cancers. He was treated with standard chemotherapy and the disease went away only to reappear a few months later. This time he received local radiation and Autologous Bone Marrow Transplantation (BMT). However, the response was shortlived and the cancer sprung its ugly head within 6 months. The young man and his distraught
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Eminent Healthcare Expert Dr Sandeep Chatrath receives the prestigious India’s Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre ILc Power Brand 2014. Dr Sandeep Chatrath also declared by the Jury as the CEO of the Year Healthcare 2014 at Asia’s Biggest Leadership Event, the 5th Annual India Leadership Conclave 2014 The prestigious & coveted Awards were presented in a glittering award ceremony
Dharamshila Hospital Urges To Join Hands To Fight Against Cancer In Children
New Delhi, June 21, 2012: Childhood cancer contributes to nearly 5% of the total cancer burden in India, with approximately 45,000 children diagnosed with cancer every year. As increasing prevalence of cancer among children is becoming a cause of great concern, there is an urgent need to spread awareness about childhood cancers, for timely detection and treatment, say doctors at Dharamshila Hospital and Research Centre, India’s first and only NABH
Dharamshila Hospital Organized A Live Workshop on Composite Resection with Micro …
New Delhi, May 5, 2012 : A live workshop on Head and Neck Cancer Surgeries was organized at Dharamshila Hospital And Research Centre (DHRC). Worldwide Head and Neck cancers are sixth most common cancers in men. In India Head and Neck Cancers are 2nd most common among men and are responsible for 40% of new cancer cases detected annually. Even though 75% of Head and Neck Cancers are caused by

All 5 Releases

More Releases for IMRT

Radiotherapy Market worth $6.8 billion by 2023 | Varian Medical Systems, Inc. (U …
The report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023", The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1% Browse 150 market data Tables and 46 Figures spread through 226 Pages and in-depth
Asia Pacific (APAC) Radiotherapy Market Analysis 2017-2024: Varian Medical Syste …
APAC Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) and Forecast to 2024 APAC Radiotherapy Market has accounted for USD 1.1 billion in 2016, and is expected to
Global Radiotherapy Market By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomothe …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic),
Radiotherapy Market 2017 – Global Industry Key Growth Factor Analysis & Resear … has added a new report to its database Global Radiotherapy Market Research Report 2017 In this report, the global Radiotherapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth
China Linear Accelerators for Radiation Therapy Market Analysis, Size, Share, Gr …
"The Report China Linear Accelerators for Radiation Therapy Market Report 2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" This report studies sales (consumption) of Linear Accelerators for Radiation Therapy in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering Varian Elekta ACCURAY Siemens Philips GE Healthcare Toshiba Mitsubishi Heavy Industries Shinva Neusoft Top Grade Healthcare View Rpeort At : Split by product types,
New radiation therapy treatment arrives at KHCC
Radiation therapy is one of the primary weapons used to fight cancer in modern medicine. Since January 1st 2010, the King Hussein Cancer Centre has begun using a new form of radiation therapy known as IMRT – Intensity Modulated Radiation Therapy. This new technique represents the very latest in medical technology to arrive at the KHCC Radiation Oncology Department, where it is currently being used to successfully treat a range